✦ LIBER ✦

PDB30 EVALUATING THE COST-EFFECTIVENESS OF BIPHASIC INSULIN ASPART 30 VERSUS HUMAN PREMIX INSULIN FOR THE TREATMENT OFTYPE 2 DIABETES IN A SPANISH SETTING

✍ Scribed by D Tucker; WJ Valentine; S Nielsen; C Townsend; R Kotchie; H Scheijbeler

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB23 COST-EFFECTIVENESS OF BIPHASIC INS

✍ M Aristides; R Kotchie; S Nielsen; C Townsend; WJ Valentine; H Scheijbeler 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PDB27 COST-EFFECTIVENESS OF BIPHASIC INS

✍ M Lynch; H Scheijbeler; R Kotchie; S Nielsen; J White; WJ Valentine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

PDB24 COST EFFECTIVENESS ANALYSIS OF SWI

✍ E Suchankova; T Doležal; Z Pisarikova; K Rychna; D Bartaskova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

COST-EFFECTIVENESS OF BIPHASIC INSULIN A

✍ Valov, Vasil; Palmer, James; Czech, Marcin; Savova, Alexandra; Petrova, Guenka 📂 Article 📅 2012 🏛 Versita 🌐 English ⚖ 413 KB

PDB11 CLINICAL AND COST-EFFECTIVENESS OF

✍ Palmer, JL; Beaudet, A; White, J; Plun-Favreau, J; Smith-Palmer, J 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

DB1 PROJECTED COST-EFFECTIVENESS OF BIPH

✍ M Aagren; TL Thomsen; VK Knudsen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB